# Research Frontiers Inc: Form 10-Q for the period ended Mar 31, 2016

- Company: [Research Frontiers Inc](/companies/refr.md) (CIK 793524)
- Form: 10-Q
- Filed: 2016-05-05
- Accepted by EDGAR: May 5, 2016, 08:31 ET
- Period: 2016-03-31
- Accession: 0001206774-16-005841
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/793524/000120677416005841/research_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/793524/000120677416005841/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2016-01-01 to 2016-03-31 | $409.1k | us-gaap:Revenues |
| Research and development | 3 months, 2016-01-01 to 2016-03-31 | $410.2k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2016-01-01 to 2016-03-31 | −$1.2m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months, 2016-01-01 to 2016-03-31 | −$1.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2016-01-01 to 2016-03-31 | −$0.05 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 3 months, 2016-01-01 to 2016-03-31 | −$1.0m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months, 2016-01-01 to 2016-03-31 | $1.6k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2016-03-31 | $4.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2016-03-31 | $7.6m | us-gaap:AssetsCurrent |
| Total assets | at 2016-03-31 | $8.5m | us-gaap:Assets |
| Current liabilities | at 2016-03-31 | $566.5k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2016-03-31 | $7.9m | us-gaap:StockholdersEquity |

## Market risk

As filed, 221 characters.

The information required by Item 3 has been disclosed in Item 7A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2015. There has been no material change in the disclosure regarding market risk.

## Controls and procedures

As filed, 3,263 characters.

### Evaluation of Disclosure Controls and Procedures

Our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act, are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We designed our disclosure controls and procedures to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officer, to allow timely decisions regarding required disclosure. Our chief executive officer and chief financial officer, with assistance from other members of our management, have reviewed the effectiveness of our disclosure controls and procedures as of March 31, 2016, and, based on their evaluation, have concluded that our disclosure controls and procedures were effective.

### Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the three months ended March 31, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

### Forward-Looking Statements

The information set forth in this Report and in all publicly disseminated information about the Company, including the narrative contained in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” above, includes “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and is subject to the safe harbor created by that section. Readers are cautioned not to place undue reliance on these forward-looking statements as they speak only as of the date hereof and are not guaranteed.

#### PART II. OTHER INFORMATION

|  |  |
| --- | --- |
| Item 6. | Exhibits |
| 31.1 | Rule 13a-14(a)/15d-14(a) Certification of Joseph M. Harary - Filed herewith. |
| 31.2 | Rule 13a-14(a)/15d-14(a) Certification of Seth L. Van Voorhees - Filed herewith. |
| 32.1 | Section 1350 Certification of Joseph M. Harary - Filed herewith. |
| 32.2 | Section 1350 Certification of Seth L. Van Voorhees - Filed herewith. |
| EX-101.INS | XBRL Instance Document |
| EX-101.SCH | XBRL Taxonomy Extension Schema |
| EX-101.PRE | XBRL Taxonomy Extension Presentation Linkbase |
| EX-101.LAB | XBRL Taxonomy Extension Label Linkbase |
| EX-101.CAL | XBRL Taxonomy Extension Calculation Linkbase |
| EX-101.DEF | XBRL Taxonomy Extension Definition Linkbase |

11

### SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunder duly authorized.

#### RESEARCH FRONTIERS INCORPORATED

(Registrant)

#### /s/ Joseph M. Harary

Joseph M. Harary, President, CEO and Treasurer

(Principal Executive)

#### /s/ Seth L. Van Voorhees

Seth L. Van Voorhees, Vice President, CFO and Treasurer

(Principal Financial and Accounting Officer)

Date: May 5, 2016

Filed May 5, 2016.
Source: SEC EDGAR, the filing index for accession 0001206774-16-005841. Last ingested by Listed: Nov 5, 2026, 16:22 ET. No prices; not investment advice.
